✦ LIBER ✦

Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial

✍ Scribed by Janet Wozniak; Joseph Biederman; Eric Mick; James Waxmonsky; Liisa Hantsoo; Catherine Best; Joanne E. Cluette-Brown; Michael Laposata

Book ID: 118436806
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 332 KB
Volume: 17
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2006.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective Open-Label Trial of Lamotr

A Prospective Open-Label Trial of Lamotrigine Monotherapy in Children and Adolescents with Bipolar Disorder

✍ Joseph Biederman; Gagan Joshi; Eric Mick; Robert Doyle; Anna Georgiopoulos; Paul 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

A prospective open-label treatment trial

A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder

✍ Joseph Biederman; Eric Mick; Thomas Spencer; Meghan Dougherty; Megan Aleardi; Ja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

A prospective open-label trial of quetia

A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder

✍ Gagan Joshi; Carter Petty; Janet Wozniak; Stephen V. Faraone; Robert Doyle; Anna 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 636 KB

P.7.024 A prospective open-label long-te

P.7.024 A prospective open-label long-term treatment trial of risperidone monotherapy in children and adolescents with bipolar disorder

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Lithium plus valproate combination thera

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 141 KB

Olanzapine monotherapy for acute depress

Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial

✍ William V. Bobo; Richard A. Epstein; Richard C. Shelton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We evaluated the efficacy, tolerability, and safety of olanzapine monotherapy in 20 adult patients with bipolar I or II disorder, depressed phase. Patients received open‐label olanzapine monotherapy (mean modal dose, 15 mg/day) for 8 weeks. Assessments of psychopathology (Montgomery–Asb